Phenylketonuria (PKU) News and Research

RSS
Improving ability to predict autism risk with few drops of blood

Improving ability to predict autism risk with few drops of blood

Investigators identify group of blood metabolites that could help detect autism

Investigators identify group of blood metabolites that could help detect autism

Compounds found in green tea and red wine offer hope to treat inborn congenital metabolic diseases

Compounds found in green tea and red wine offer hope to treat inborn congenital metabolic diseases

FDA approves novel enzyme therapy for adults with rare and serious genetic disease

FDA approves novel enzyme therapy for adults with rare and serious genetic disease

Pediatric researchers uncover new syndrome that causes intellectual disability

Pediatric researchers uncover new syndrome that causes intellectual disability

MU researchers use MRI to study effects of Phenylketonuria

MU researchers use MRI to study effects of Phenylketonuria

Flagship launches Rubius to develop functionalized red blood cells for treatment of serious diseases

Flagship launches Rubius to develop functionalized red blood cells for treatment of serious diseases

Intrexon, Synthetic Biologics form ECC to develop and commercialize novel biotherapeutics for phenylketonuria

Intrexon, Synthetic Biologics form ECC to develop and commercialize novel biotherapeutics for phenylketonuria

Newborn screening can prevent lifelong disability

Newborn screening can prevent lifelong disability

Parents must be considered during expansion of genetic screening programs for newborns

Parents must be considered during expansion of genetic screening programs for newborns

AHRQ grants U-M $2.5M to study long-term health outcomes and cost-effectiveness of newborn screening

AHRQ grants U-M $2.5M to study long-term health outcomes and cost-effectiveness of newborn screening

Pediatric research project to expand data collection linked to newborn screening results

Pediatric research project to expand data collection linked to newborn screening results

State laws regarding baby blood samples analyzed

State laws regarding baby blood samples analyzed

Expansion of newborn screening throws some families on a journey of great uncertainty

Expansion of newborn screening throws some families on a journey of great uncertainty

BioMarin commences Phase 3b study of Kuvan's neuropsychiatric effects in phenylketonuria patients

BioMarin commences Phase 3b study of Kuvan's neuropsychiatric effects in phenylketonuria patients

BioMarin provides update on PEG-PAL Phase 2 clinical study for phenylketonuria

BioMarin provides update on PEG-PAL Phase 2 clinical study for phenylketonuria

BioMarin Pharmaceutical reports GAAP net income of $4.7M for fourth-quarter 2009

BioMarin Pharmaceutical reports GAAP net income of $4.7M for fourth-quarter 2009

Call for every health insurance plan to cover Phenylketonuria

Call for every health insurance plan to cover Phenylketonuria

Patent covering the approved administration of Kuvan with food issued

Patent covering the approved administration of Kuvan with food issued

BioMarin commences PEG-PAL Phase 2 clinical trial for phenylketonuria

BioMarin commences PEG-PAL Phase 2 clinical trial for phenylketonuria